Academy Capital Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$26.4M Buy
719,230
+353,447
+97% +$16.7M 3.78% 12
2025
Q4
$18.6M Sell
365,783
-1,636
-0.4% -$83.7K 2.47% 14
2025
Q3
$20.4M Buy
367,419
+1,170
+0.3% +$68.5K 2.91% 13
2025
Q2
$25.3M Sell
366,249
-1,325
-0.4% -$90.1K 3.61% 12
2025
Q1
$25.5M Buy
367,574
+213,453
+138% +$17.6M 4.4% 11
2024
Q4
$13.3M Buy
+154,121
New +$16.7M 2.17% 13

Other funds holding NVO

Academy Capital Management's NVO Position: Q1 2026 in Review

Academy Capital Management increased its Novo Nordisk (NVO) stake by 97% in Q1 2026, buying an estimated $16.7M and bringing the position to 719,230 shares worth $26.4M. The position accounts for 3.78% of the portfolio, ranked #12.

Academy Capital Management first reported a position in NVO in Q4 2024 and has held it in 6 quarters since. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Academy Capital Management held 719,230 shares of Novo Nordisk worth $26.4M as of Q1 2026.
  • Academy Capital Management bought 353,447 Novo Nordisk shares in Q1 2026, an estimated $16.7M.
  • Novo Nordisk made up 3.78% of Academy Capital Management's portfolio in Q1 2026, its #12 holding.
  • Academy Capital Management first reported a position in Novo Nordisk in Q4 2024 and has held it in 6 quarters since.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Academy Capital Management's 13F filing for Q1 2026, filed 14 May 2026.